Papers - Kurose Kouichi

副作用バイオマーカーの探索と臨床応用研究の現状について

斎藤嘉朗，中村亮介，黒瀬光一 , 2013.09

臨床病理レビュー

Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development.

Kurose K, Sugiyama E, Saito Y. , 2012.09

Drug Metab Pharmacokinet.

Development of a rapid and inexpensive assay for detecting a surrogate genetic polymorphism of HLA-B*58:01: a partially predictive but useful biomarker for allopurinol-related Stevens-Johnson syndrome/toxic epidermal necrolysis in Japanese

Maekawa K, Nishikawa J, Kaniwa N, Sugiyama E, Koizumi T, Kurose K, et al. , 2012.09

Drug Metab Pharmacokinet.

Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression

Kurose K, Hiratsuka K, Ishiwata K, et al. , 2012.09

Psychiatry Res.

Genetic polymorphisms of FCGR2A encoding Fcγ receptor IIa in a Japanese population and functional analysis of the L273P variant

Tada M, Ishii-Watabe A, Maekawa K, Fukushima-Uesaka H, Kurose K,et al. , 2012.09

Immunogenetics

Quality requirements for genomic DNA preparations and storage conditions for a high-density oligonucleotide microarray

Kurose K, Koizumi T, Nishikawa J, Maekawa K, Saito Y. , 2012.09

Biol Pharm Bull.

ゲノム情報に基づいた副作用予測.

黒瀬光一，斎藤嘉朗 , 2012.02

日本臨牀

Genetic variation and haplotype structures of the glutathione S-transferase genes, GSTA1 and GSTA2 in Japanese colorectal cancer patients.

Maekawa K, Hamaguchi T, Saito Y, Tatewaki N, Kurose K, Kaniwa N, Nakajima TE, Kato K, Yamada Y, Shimada Y, Yoshida T, Kamatani N, Ura T, Saito M, Muro K, Fuse N, Yoshino T, Doi T, Otsu A, Saijo N, Sawada J, Okuda H, Matsumura Y. , 2011.09

Drug Metab. Pharmacokinet.

Functional analysis of genetic variations in the 5'-flanking region of the human MDR1 gene.

Saeki M, Kurose K, Hasegawa R, Tohkin M , 2011.09

Molecular Genetics and Metabolism

Genetic polymorphisms and haplotypes of POR, encoding cytochrome P450 oxidoreductase, in a Japanese population

Saito Y, Yamamoto N, Katori N, Maekawa K, Fukushima-Uesaka H, Sugimoto D, Kurose K, Sai K, Kaniwa N, Sawada J, Kunitoh H, Ohe Y, Yoshida T, Matsumura Y, Saijo N, Okuda H, Tamura T. , 2011.09

Drug Metab. Pharmacokinet.

Genetic variations of orosomucoid genes associated with serum alpha-1-acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer patients.

Katori N, Sai K, Saito Y, Fukushima-Uesaka H, Kurose K, Yomota C, Kawanishi T, Nishimaki-Mogami T, Naito M, Sawada J, Kunitoh H, Nokihara H, Sekine I, Ohe Y, Yoshida T, Matsumura Y, Saijo N, Yamamoto N, Okuda H, Tamura T. , 2011.09

J. Pharm. Sci.

Genetic polymorphisms of FCGRT encoding FcRn in a Japanese population and their functional analysis.

Ishii-Watabe A, Saito Y, Suzuki T, Tada M, Ukaji M, Maekawa K, Kurose K, Kaniwa N, Sawada J, Kawasaki N, Yamaguchi T, Eguchi Nakajima T, Kato K, Yamada Y, Shimada Y, Yoshida T, Ura T, Saito M, Muro K, Doi T, Fuse N, Yoshino T, Ohtsu A, Saijo N, Hamaguchi T, Okuda H, Matsumura Y , 2010.09

Drug Metab. Pharmacokinet.

HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.

Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Furuya H, Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R, JSAR research group. , 2010.09

Epilepsia

Prediction of severe adverse drug reactions from pharmacogenetic biomarkers, drug metabolism and pharmacokinetics.

Tohkin M, Ishiguro A, Kaniwa N, Saito Y, Kurose K, Hasegawa R , 2010.09

Drug Metab. Pharmacokinet.

Genetic polymorphisms of copper- and platinum drug- efflux transporters ATP7A and ATP7B in Japanese cancer patients.

Fukushima-Uesaka H, Saito Y, Maekawa K, Kurose K, Sugiyama E, Katori N, Kaniwa N, Hasegawa R, Hamaguchi T, Eguchi-Nakajima T, Kato K, Yamada Y, Shimada Y, Yoshida T, Yamamoto N, Nokihara H, Kunitoh H, Ohe Y, Tamura T, Ura T, Saito M, Muro K, Doi T, Fuse N, Yoshino T, Ohtsu A, Saijo N, Matsumura Y, Okuda H, Sawada J. , 2009.09

Drug Metab. Pharmacokinet.

Genetic variations and haplotype structures of the glutathione S-transferase genes, GSTT1 and GSTM1, in a Japanese patient population.

Tatewaki N, Maekawa K, Katori N, Kurose K, Kaniwa N, Yamamoto N, Kunitoh H, Ohe Y, Nokihara H, Sekine I, Tamura T, Yoshida T, Saijo N, Saito Y, Sawada J. , 2009.09

Drug Metab. Pharmacokinet.

Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population

Sai K, Saito Y, Itoda M, Fukushima-Uesaka H, Nishimaki-Mogami T, Ozawa S, Maekawa K, Kurose K, et al. , 2008.09

Drug Metabolism and Pharmacokinetics

Importance of UDP-glucuronosyltransferase 1A1 *6 for irinotecan toxicities in Japanese cancer patients.

Sai K, Saito Y, Sakamoto H, Shirao K, Kurose K, et al. , 2008.09

Cancer Lett.

Thyroid hormone receptor mediates human MDR1 gene expression — identification of the response region essential for gene expression

Kurose K, Saeki M, Tohkin M, Hasegawa R , 2008.09

Archives of Biochemistry and Biophysics

Impact of CYP3A4 haplotypes on irinotecan pharmacokinetics in Japanese cancer patients

Sai K, Saito Y, Fukushima-Uesaka H, Kurose K, et al. , 2008.09

Cancer Chemother. Pharmacol.